Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human CD30/TNFRSF8 (Research Grade Brentuximab Biosimilar) Alexa Fluor 700-conjugated Antibody, R&D Systems™

Human Monoclonal Antibody
Supplier: R&D Systems FAB9576N100UG
This item is not returnable.
View return policy
Description
CD30/TNFRSF8 Monoclonal specifically detects CD30/TNFRSF8 in Human samples. It is validated for Flow Cytometry.Specifications
CD30/TNFRSF8 | |
Monoclonal | |
Alexa Fluor 700 | |
Supplied 0.2 mg/mL in a saline solution containing BSA and Sodium Azide. | |
Human | |
Protein A or G purified from cell culture supernatant | |
Primary | |
Detects human CD30/TNFRSF8 in direct ELISAs. This non-therapeutic antibody uses the same variable region sequence as the therapeutic antibody Brentuximab. This product is for research use only. | |
Protect from light. Do not freeze. 12 months from date of receipt, 2 to 8 degreesC as supplied. | |
IgG1 |
Flow Cytometry | |
Hu8 | |
Flow Cytometry 0.25-1 ug/10^6 cells | |
CD30, CD30 antigen, CD30KI-1, CD30L receptor, cytokine receptor CD30, D1S166EKi-1, Ki-1 antigen, Lymphocyte activation antigen CD30, TNFRSF8, tumor necrosis factor receptor superfamily member 8, tumor necrosis factor receptor superfamily, member 8 | |
Human CD30/TNFRSF8 | |
100 μg | |
943 | |
Human | |
Supernatant |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction